CEL-SCI Announces Closing of $2.5 Million Offering
SCI Corporation ("CEL-SCI" or the "Company") (NYSE American: CVM), a Phase 3 cancer immunotherapy company, today announced ...
Mirage News13 小时
LOWVELO Performer Cancer-Free 15 Years Post-Diagnosis
He didn't feel sick at all.Nathan Calhoun was young, he was fit, he was in a brand-new relationship, he had just started a ...
Iovance: The Company Makes It Hard To Estimate Revenue Growth
Discover Iovance's Q4'24 revenue growth, Proleukin's impact on Amtagvi's future, and how it faces competition like Obsidian's ...
Medscape18 小时
For Psoriasis, Should Dermatologists Treat Obesity?
Join Drs Steven Feldman and Robert Kushner as they discuss the role of dermatologists in treating obesity in conjunction with psoriasis.
Coya Therapeutics Provides a Corporate Update and Reports Fiscal 2024 Financial Results
Coya Therapeutics, Inc. (Nasdaq: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function, provides a ...
Medscape23 小时
Dupilumab Boosts Lung Function in Patients With Type 2 Asthma
In a phase 4 trial, dupilumab effectively reduces airway inflammation and mucus plugging, improving lung function and asthma control in patients with moderate to severe type 2 asthma.